NPI: 1730173550 · DARBY, PA 19023 · General Acute Care Hospital · NPI assigned 09/08/2005
Authorized official CUMMINGS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | CUMMINGS, KIMBERLY (VP, FINANCE AND CFO) |
| Parent Organization | MERCY CATHOLIC MEDICAL CENTER OF SOUTHEASTERN PA |
| NPI Enumeration Date | 09/08/2005 |
Other providers sharing the same authorized official: CUMMINGS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 133 | $546.97 |
| 2019 | 476 | $92K |
| 2020 | 31,486 | $2.62M |
| 2021 | 78,632 | $9.88M |
| 2022 | 24,257 | $5.74M |
| 2023 | 48,164 | $5.64M |
| 2024 | 44,714 | $3.87M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 25,327 | 24,411 | $6.85M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 17,543 | 16,741 | $5.41M |
| G0378 | Hospital observation service, per hour | 2,206 | 1,775 | $3.91M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,949 | 6,538 | $2.36M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8,743 | 8,469 | $2.17M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 985 | 928 | $1.52M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 936 | 879 | $1.48M |
| T1015 | Clinic visit/encounter, all-inclusive | 7,539 | 2,110 | $828K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 223 | 213 | $278K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,273 | 2,144 | $223K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,115 | 1,105 | $222K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 798 | 769 | $166K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 675 | 363 | $147K |
| 73564 | 2,831 | 1,987 | $141K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 640 | 357 | $121K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 606 | 593 | $108K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,980 | 820 | $100K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 343 | 332 | $84K |
| 76830 | Ultrasound, transvaginal | 647 | 641 | $78K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 469 | 458 | $77K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13,964 | 11,351 | $72K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 749 | 424 | $71K |
| 77066 | Tomosynthesis, mammo | 279 | 273 | $59K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 745 | 740 | $56K |
| 92557 | 759 | 739 | $51K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 88 | 85 | $49K |
| 94729 | 694 | 681 | $48K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,614 | 1,532 | $47K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,094 | 1,084 | $46K |
| 93975 | 310 | 298 | $45K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,618 | 5,471 | $44K |
| 76642 | 421 | 329 | $42K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,442 | 5,022 | $39K |
| 80053 | Comprehensive metabolic panel | 4,188 | 3,288 | $38K |
| 94727 | 687 | 674 | $35K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,908 | 1,496 | $33K |
| 85027 | 2,073 | 1,941 | $32K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 66 | 64 | $29K |
| 77065 | Tomosynthesis, mammo | 151 | 146 | $26K |
| 76770 | 229 | 225 | $23K | |
| 74183 | 28 | 27 | $22K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 154 | 152 | $21K |
| 93970 | 136 | 132 | $21K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 915 | 327 | $20K |
| 92567 | 773 | 756 | $20K | |
| 93017 | 199 | 193 | $19K | |
| 71046 | Radiologic examination, chest; 2 views | 559 | 550 | $19K |
| 73030 | 543 | 470 | $18K | |
| 71250 | 157 | 157 | $17K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,059 | 1,026 | $17K |
| 94375 | 252 | 247 | $16K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 110 | 104 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 871 | 816 | $15K |
| 97162 | 277 | 267 | $14K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 38 | 36 | $14K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 113 | 112 | $14K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 154 | 149 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,838 | 3,511 | $14K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 40 | 39 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 219 | 215 | $13K |
| 73610 | 390 | 352 | $12K | |
| 73502 | 299 | 267 | $12K | |
| 36415 | Collection of venous blood by venipuncture | 11,790 | 9,228 | $12K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,529 | 1,409 | $11K |
| 86900 | 701 | 675 | $11K | |
| 93325 | 54 | 54 | $10K | |
| 93971 | 112 | 108 | $10K | |
| 80061 | Lipid panel | 781 | 764 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | 527 | 500 | $9K |
| 85610 | 1,577 | 1,300 | $8K | |
| 77062 | 102 | 102 | $8K | |
| 94060 | 226 | 222 | $8K | |
| 97597 | 130 | 103 | $8K | |
| 70450 | Computed tomography, head or brain; without contrast material | 501 | 477 | $8K |
| 96417 | 54 | 37 | $7K | |
| 73630 | 379 | 329 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 664 | 538 | $7K |
| 80050 | General health panel | 67 | 67 | $7K |
| 73130 | 345 | 289 | $6K | |
| 72100 | 119 | 118 | $6K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 87 | 83 | $6K |
| 72110 | 104 | 104 | $5K | |
| 87081 | 749 | 738 | $5K | |
| 71045 | Radiologic examination, chest; single view | 2,615 | 2,442 | $5K |
| 83735 | 3,609 | 2,719 | $5K | |
| C1769 | Guide wire | 31 | 27 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | 764 | 735 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 904 | 865 | $5K |
| 93350 | 28 | 28 | $4K | |
| 80076 | 1,649 | 1,514 | $4K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 101 | 70 | $4K |
| 82805 | 414 | 389 | $4K | |
| 97161 | 90 | 90 | $4K | |
| 76981 | 67 | 64 | $4K | |
| 73110 | 174 | 147 | $4K | |
| 93320 | 41 | 41 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 93 | 90 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 529 | 431 | $4K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 586 | 560 | $3K |
| 73562 | 69 | 49 | $3K | |
| 80177 | 135 | 123 | $3K | |
| 96415 | 35 | 25 | $3K | |
| 81001 | 732 | 708 | $3K | |
| 71271 | 12 | 12 | $3K | |
| 83880 | 438 | 401 | $3K | |
| 36600 | 414 | 388 | $3K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 44 | 42 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | 460 | 389 | $3K |
| 84484 | 1,586 | 1,364 | $2K | |
| 80164 | 56 | 52 | $2K | |
| 95806 | 13 | 13 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 546 | 517 | $2K |
| 83690 | 1,677 | 1,545 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 50 | 45 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 140 | 130 | $2K |
| 84702 | 408 | 378 | $2K | |
| 0011A | 41 | 40 | $2K | |
| 85730 | 826 | 766 | $2K | |
| 76536 | 14 | 14 | $2K | |
| 93923 | 12 | 12 | $1K | |
| 0012A | 23 | 23 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 292 | 284 | $1K |
| 86885 | 198 | 181 | $1K | |
| 97163 | 16 | 16 | $1K | |
| 96367 | 29 | 24 | $1K | |
| 82728 | 89 | 87 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | 12 | 12 | $998.16 |
| 82550 | 817 | 767 | $983.22 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 649 | 623 | $980.47 |
| 82248 | 565 | 517 | $961.23 | |
| 84466 | 48 | 48 | $910.83 | |
| J2704 | Injection, propofol, 10 mg | 3,495 | 3,140 | $901.06 |
| 93041 | 916 | 866 | $864.96 | |
| 84100 | 1,074 | 712 | $795.46 | |
| 88342 | 187 | 182 | $776.36 | |
| 82607 | 47 | 43 | $762.38 | |
| 36591 | 33 | 29 | $725.01 | |
| 86901 | 232 | 210 | $643.93 | |
| 86140 | 103 | 88 | $620.76 | |
| 82043 | 80 | 79 | $619.55 | |
| 83540 | 64 | 63 | $617.98 | |
| 85652 | 94 | 81 | $611.97 | |
| 87077 | 117 | 114 | $598.38 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 53 | 51 | $566.78 |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 133 | 132 | $546.97 |
| 82330 | 391 | 366 | $535.42 | |
| 90715 | 40 | 40 | $522.23 | |
| 83605 | 423 | 391 | $516.22 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,151 | 3,378 | $512.30 |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 223 | 78 | $501.07 |
| 81025 | 1,614 | 1,497 | $495.39 | |
| 76857 | 12 | 12 | $477.38 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,051 | 1,578 | $473.42 |
| 84153 | 27 | 27 | $471.79 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 12 | 12 | $426.58 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 220 | 96 | $399.23 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 417 | 315 | $362.61 |
| J1170 | Injection, hydromorphone, up to 4 mg | 511 | 334 | $349.24 |
| 97116 | 21 | 14 | $316.32 | |
| 84439 | 50 | 47 | $312.72 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 58 | 55 | $310.96 |
| 81003 | 194 | 192 | $300.26 | |
| 82077 | 229 | 221 | $233.10 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,617 | 1,961 | $220.09 |
| J0690 | Injection, cefazolin sodium, 500 mg | 332 | 278 | $217.05 |
| 87186 | 24 | 24 | $213.60 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 12 | 12 | $212.12 |
| 73590 | 15 | 12 | $204.29 | |
| 85014 | 72 | 72 | $192.85 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 889 | 711 | $188.56 |
| 86850 | 26 | 26 | $168.51 | |
| 82746 | 12 | 12 | $164.02 | |
| 76801 | 13 | 13 | $153.56 | |
| J1644 | Injection, heparin sodium, per 1000 units | 928 | 592 | $153.29 |
| 82947 | 12 | 12 | $126.76 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,463 | 1,152 | $122.13 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,089 | 1,890 | $98.93 |
| 80051 | 37 | 36 | $90.42 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 91 | 89 | $81.00 |
| 94760 | 12 | 12 | $65.73 | |
| 85379 | 51 | 51 | $57.47 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,726 | 1,600 | $53.17 |
| 88304 | 80 | 78 | $52.67 | |
| J7050 | Infusion, normal saline solution, 250 cc | 1,506 | 864 | $45.63 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 586 | 523 | $42.26 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 356 | 227 | $30.09 |
| A9270 | Non-covered item or service | 5,247 | 2,759 | $14.19 |
| 84295 | 86 | 81 | $13.06 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,318 | 3,780 | $12.90 |
| 84132 | 91 | 86 | $12.74 | |
| 82435 | 86 | 81 | $12.74 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,253 | 1,015 | $10.46 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 157 | 141 | $5.67 |
| J2060 | Injection, lorazepam, 2 mg | 274 | 223 | $2.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 116 | 105 | $0.80 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,010 | 895 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 417 | 400 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 273 | 227 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 712 | 377 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,671 | 1,448 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 565 | 286 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 274 | 267 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 27 | 25 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 15 | 12 | $0.00 |
| J2251 | Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg | 25 | 25 | $0.00 |
| 87400 | 14 | 14 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 23 | 12 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 64 | 46 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 23 | 15 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 373 | 352 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 159 | 140 | $0.00 |
| 96376 | 41 | 38 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 484 | 187 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 73 | 66 | $0.00 |